Literature DB >> 7139456

Diazepam withdrawal syndrome: its prolonged and changing nature.

C S Mellor, V K Jain.   

Abstract

The diazepam withdrawal syndrome was studied in 10 patients who had abused the drug for 3 to 14 years. In the previous 6 months their consumption of diazepam had ranged from 60 to 120 mg daily; none had used other drugs during this period. The withdrawal period lasted about 6 weeks. The intensity of the symptoms and signs was high initially, fell during the first 2 weeks, then rose again in the third week, before finally declining. Three groups of symptoms and signs were identified. Group A symptoms occurred throughout withdrawal and included tremor, anorexia, insomnia and myoclonus. Group B symptoms and signs were largely confined to the first 10 days and were those of a toxic psychosis. Group C symptoms reached a peak in the third and fourth weeks of withdrawal and were characterized by sense perceptions that were either heightened or lowered. The symptom groups, the presence of tremor and myoclonus, and the relief of symptoms by a test dose permit diazepam withdrawal to be distinguished from anxiety. The biphasic course of the symptoms is probably related to the pharmacokinetics of diazepam.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139456      PMCID: PMC1862031     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  17 in total

1.  Diazepam withdrawal psychosis: a case report.

Authors:  M W Dysken; C H Chan
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

2.  Withdrawal reaction to diazepam.

Authors:  A Rifkin; F Quitkin; D F Klein
Journal:  JAMA       Date:  1976-11-08       Impact factor: 56.272

3.  Letter: Diazepam withdrawal fits.

Authors:  I Vyas; M W Carney
Journal:  Br Med J       Date:  1975-10-04

4.  Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline.

Authors:  G Tognoni; R Gomeni; D De Maio; G G Alberti; P Franciosi; G Scieghi
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

5.  Benzodiazepines and withdrawal psychosis. Report of three cases.

Authors:  S H Preskorn; L J Denner
Journal:  JAMA       Date:  1977-01-03       Impact factor: 56.272

6.  Plasma concentrations of benzodiazepines.

Authors:  A J Bond; D M Hailey; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

7.  Comparison of the pharmacokinetics of diazepam after single and subchronic doses.

Authors:  U Klotz; K H Antonin; P R Bieck
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

9.  Withdrawal symptoms in neonates from intrauterine exposure to diazepam.

Authors:  J L Rementería; K Bhatt
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

10.  Abrupt withdrawal from therapeutically administered diazepam. Report of a case.

Authors:  J S Pevnick; D R Jasinski; C A Haertzen
Journal:  Arch Gen Psychiatry       Date:  1978-08
View more
  9 in total

Review 1.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

2.  Withdrawal from benzodiazepines of short half-life.

Authors:  D F Craig
Journal:  CMAJ       Date:  1988-12-01       Impact factor: 8.262

3.  Benzodiazepines: dependence and a therapeutic approach to gradual withdrawal.

Authors:  D Blais; L Petit
Journal:  Can Fam Physician       Date:  1990-10       Impact factor: 3.275

4.  Diazepam withdrawal syndrome.

Authors:  E M Sellers; U Busto
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

5.  Benzodiazepines: are we overprescribing?

Authors:  V Schiralli; M McIntosh
Journal:  Can Fam Physician       Date:  1987-04       Impact factor: 3.275

6.  Benzodiazépines: dépendance et approche thérapeutique pour un retrait graduel.

Authors:  D Blais; B Pharm; L P Pharm
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

Review 7.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  The role of drugs in the treatment of alcoholism.

Authors:  J E Peachey; C A Naranjo
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

9.  Surviving Benzodiazepines: A Patient's and Clinician's Perspectives.

Authors:  Carrie M Silvernail; Steven L Wright
Journal:  Adv Ther       Date:  2022-03-03       Impact factor: 4.070

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.